QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of SchizophreniaMohamed El fadili, Menana Elhallaoui, Sara Zarougui et al.|Pharmaceuticals|2022Cited by 71
3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor AntagonistsMohamed El fadili, Menana Elhallaoui, Mohammed Er-rajy et al.|Processes|2022Cited by 53
In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigationsMohamed El fadili, Menana Elhallaoui, Mohammed Er-rajy et al.|BMC Chemistry|2024Cited by 29
In-silico screening based on molecular simulations of 3,4-disubstituted pyrrolidine sulfonamides as selective and competitive GlyT1 inhibitorsMohamed El fadili, Menana Elhallaoui, Mohammed Er-rajy et al.|Arabian Journal of Chemistry|2023Cited by 28
An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agentsMohamed El fadili, Menana Elhallaoui, Mohammed Er-rajy et al.|Journal of Biomolecular Structure and Dynamics|2023Cited by 26